Literature DB >> 4003300

Morphology of ventricular septal defect in complete transposition of the great arteries.

R J Moene, A Oppenheimer-Dekker, A C Wenink, M M Bartelings, A C Gittenberger-de Groot.   

Abstract

The morphologic characteristics of ventricular septal defect (VSD) was studied in 50 hearts with complete transposition of the great arteries. Except for 1 membranous and 1 subarterial defect, all VSDs could be classified into 1 of 4 categories. Group A included 14 specimens with a perimembranous defect extending into inlet and trabecular septum with rightward malalignment of the outlet septum; in this group aortic arch anomalies (6 hearts) and tricuspid valve abnormalities (7 hearts) were frequently present. Group B comprised 13 hearts with perimembranous defects extending into the inlet septum; 11 hearts in this group also had an anomalous mitral valve. Group C included 13 hearts with muscular inlet defects, with signs of spontaneous closure by marginal fibrosis in 10 cases. Group D included 8 hearts with muscular infundibular defects; in 6 of these hearts the outlet septum was malaligned to the left, causing different degrees of subpulmonary stenosis. A small second VSD was present in 5 hearts. Thus, the spectrum of VSD in transposition of the great arteries is different from that of isolated VSD.

Entities:  

Mesh:

Year:  1985        PMID: 4003300     DOI: 10.1016/0002-9149(85)90974-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Complex complete transposition of great arteries and partial anomalous pulmonary venous connection with an intact interatrial septum-lessons learnt.

Authors:  Aayush Poddar; Vijayakumar Raju; Preethi Nandhini; Soundaravalli Balakrishnan; Kalyanasundaram Muthuswamy
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-10-25

2.  Comparison of types of pulmonary stenosis with the state of the ventricular septum in complete transposition of the great arteries.

Authors:  M Silberbach; W L Castro; M A Goldstein; R V Lucas; J E Edwards
Journal:  Pediatr Cardiol       Date:  1989       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.